BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27358215)

  • 61. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
    Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation.
    Iguchi A; Terashita Y; Sugiyama M; Ohshima J; Sato TZ; Cho Y; Kobayashi R; Ariga T
    Pediatr Transplant; 2016 Feb; 20(1):114-9. PubMed ID: 26526424
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gastrointestinal inflammation after bone marrow transplantation: graft-versus-host disease or opportunistic infection?
    Jones B; Kramer SS; Saral R; Beschorner WE; Yolken RH; Townsend TR; Yeager AM; Lake A; Tutschka P; Santos GW
    AJR Am J Roentgenol; 1988 Feb; 150(2):277-81. PubMed ID: 3276085
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Junctional proteins of keratinocytes in Grover's disease, Hailey-Hailey's disease and Darier's disease.
    Hashimoto K; Fujiwara K; Harada M; Setoyama M; Eto H
    J Dermatol; 1995 Mar; 22(3):159-70. PubMed ID: 7537767
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
    Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Basis for a neuronal version of Grover's quantum algorithm.
    Clark KB
    Front Mol Neurosci; 2014; 7():29. PubMed ID: 24860419
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
    Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
    Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Is Grover's disease an autoimmune dermatosis?
    Phillips C; Kalantari-Dehaghi M; Marchenko S; Chernyavsky AI; Galitovskiy V; Gindi V; Chun S; Paslin D; Grando SA
    Exp Dermatol; 2013 Dec; 22(12):781-4. PubMed ID: 24131368
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA; Ildstad ST
    Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow.
    Sakamoto K; Sachs DH; Shimada S; Popitz-Bergez FA; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Katz SI; Gress RE
    Transplantation; 1988 May; 45(5):869-75. PubMed ID: 3285532
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A case of pityriasis rubra pilaris with associated focal acantholytic dyskeratosis complicated by Kaposi's varicelliform eruption.
    Erdag G; Lockman D; Tromberg J; Cropley T; Patterson JW
    J Cutan Pathol; 2011 Nov; 38(11):919-22. PubMed ID: 21732959
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Grover's disease associated with Sarcoptes scabiei.
    Kaddu S; Müllegger RR; Kerl H
    Dermatology; 2001; 202(3):252-4. PubMed ID: 11385234
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Calcineurin and mTOR Inhibitor-Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study.
    Al-Homsi AS; Cole K; Muilenburg M; Goodyke A; Abidi M; Duffner U; Williams S; Parker J; Abdel-Mageed A
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1651-1657. PubMed ID: 28549771
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.